Inspire Medical Systems Inc.
Inspire Medical Systems Inc. (INSP): 2 pipeline candidates · 1 upcoming catalyst · ~6 mo cash runway · 9 clinical trials. Updated within the last hour.
BioSniper Score
6-factor signal · derived from public data
6.1 months
D/E 0.15 · 0% dilution
Lead: Approved
2 candidates
1 upcoming, next in ~469d
0 buys · 4 sells (180d)
A transparent, data-derived signal for Inspire Medical Systems Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$1.2B
Cash
$98.9M
Quarterly Burn
$178.0M
Runway
6.1 mo
Revenue
$204.6M
Cash Runway vs Catalysts
A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| inspire programmer system | Phase 3 |
| inspire system | Approved |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
301
Total value held
$1.82B
| Holder | Shares | Value |
|---|---|---|
| blackrock, inc. | 3,549,554 | $183.1M |
| deerfield management company, l.p. | 2,703,238 | $139.4M |
| wellington management group llp | 2,535,954 | $130.8M |
| vanguard capital management llc | 2,533,476 | $130.7M |
| vanguard portfolio management llc | 1,637,173 | $84.4M |
| morgan stanley | 1,450,634 | $74.8M |
| d. e. shaw & co., inc. | 1,199,637 | $61.9M |
| william blair investment management, llc | 1,137,384 | $58.7M |
| state street corp | 956,011 | $49.3M |
| walleye capital llc | 718,778 | $37.1M |
Showing top 10 of 301 institutional holders of Inspire Medical Systems Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Inspire Medical Systems Inc.'s pipeline?
Inspire Medical Systems Inc. (INSP) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Inspire Medical Systems Inc.'s lead drug candidate?
Inspire Medical Systems Inc.'s most advanced tracked candidate is inspire programmer system (Phase 3) for Anesthesiology.
What is Inspire Medical Systems Inc.'s next catalyst?
Inspire Medical Systems Inc.'s next tracked catalyst is a Phase3_Topline event — "Phase 3 Topline: Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive " — expected September 30, 2027.
What is Inspire Medical Systems Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Inspire Medical Systems Inc. has approximately 6.1 months of cash runway.
What is Inspire Medical Systems Inc.'s market capitalization?
Inspire Medical Systems Inc.'s market capitalization is approximately $1.2B.
Get the full picture on Inspire Medical Systems Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.